{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:02Z","timestamp":1759048142707},"reference-count":11,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,2,5]]},"DOI":"10.1182\/blood-2014-12-615302","type":"journal-article","created":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T17:30:09Z","timestamp":1423157409000},"page":"892-893","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Serum cytokines in follicular lymphoma"],"prefix":"10.1182","volume":"125","author":[{"given":"Eva","family":"Kimby","sequence":"first","affiliation":[{"name":"KAROLINSKA INSTITUTE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111818584402900_B1","article-title":"Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma.","volume-title":"Blood","author":"Mir"},{"issue":"21","key":"2019111818584402900_B2","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"issue":"34","key":"2019111818584402900_B3","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2006.06.4766","article-title":"Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.","volume":"24","author":"Alvaro","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111818584402900_B4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","article-title":"Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.","volume":"25","author":"Glas","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111818584402900_B5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2009-07-235598","article-title":"The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation.","volume":"115","author":"Farinha","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111818584402900_B6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1158\/1078-0432.CCR-09-2487","article-title":"A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1\u2013positive, regulatory, cytotoxic, and helper T cells and macrophages.","volume":"16","author":"Wahlin","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2019111818584402900_B7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3324\/haematol.2013.095257","article-title":"The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium.","volume":"99","author":"Sander","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"2019111818584402900_B8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.13574","article-title":"Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.","volume":"94","author":"de Jong","year":"2009","journal-title":"Haematologica"},{"issue":"3","key":"2019111818584402900_B9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2007.12.8298","article-title":"High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.","volume":"26","author":"Canioni","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111818584402900_B10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00277-009-0777-8","article-title":"Serum cytokines in follicular lymphoma. Correlation of TGF-\u03b2 and VEGF with survival.","volume":"89","author":"Labidi","year":"2010","journal-title":"Ann Hematol"},{"issue":"10","key":"2019111818584402900_B11","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2011-03-340885","article-title":"Soluble IL-2R\u03b1 facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.","volume":"118","author":"Yang","year":"2011","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/125\/6\/892\/1386898\/892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/125\/6\/892\/1386898\/892.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T23:58:57Z","timestamp":1574121537000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/125\/6\/892\/34056\/Serum-cytokines-in-follicular-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,2,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-12-615302","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]}}}